Microencapsulation of alpha-mangostin into PLGA microspheres and optimization using response surface methodology intended for pulmonary delivery

Documented to exhibit cytotoxicity and poor oral bioavailability, alpha-mangostin was encapsulated into PLGA microspheres with optimization of formulation using response surface methodology. Mixed levels of four factors Face central composite design was employed to evaluate critical formulation vari...

Full description

Bibliographic Details
Main Authors: Elsaid Ali, Aimen Abdo, Bakhtiar, M. Taher, Mohamed, Farahidah
Format: Article
Language:English
Published: Informa Healthcare 2013
Subjects:
Online Access:http://irep.iium.edu.my/31882/1/Microencapsulation_of_alpha_mangostin_J_Micro.pdf
_version_ 1825647456101072896
author Elsaid Ali, Aimen Abdo
Bakhtiar, M. Taher
Mohamed, Farahidah
author_facet Elsaid Ali, Aimen Abdo
Bakhtiar, M. Taher
Mohamed, Farahidah
author_sort Elsaid Ali, Aimen Abdo
collection IIUM
description Documented to exhibit cytotoxicity and poor oral bioavailability, alpha-mangostin was encapsulated into PLGA microspheres with optimization of formulation using response surface methodology. Mixed levels of four factors Face central composite design was employed to evaluate critical formulation variables. With 30 runs, optimized formula was 1% w/v polyvinyl alcohol, 1:10 ratio of oil to aqueous and sonicated at 2 and 5 min time for primary and secondary emulsion, respectively. Optimized responses for encapsulation efficiency, particle size and polydispersity index were found to be 39.12 ± 0.01%, 2.06 ± 0.017 µm and 0.95 ± 0.009, respectively, which matched values predicted by mathematical models. About 44.4% of the encapsulated alpha-mangostin was released over 4 weeks. Thermal analysis of the microspheres showed physical conversion of alpha-mangostin from crystallinity to amorphous with encapsulated one had lower in vitro cytotoxicity than free alpha-mangostin. Aerodynamic diameter (784.3 ± 7.5 nm) of this alpha-mangostin microsphere suggests suitability for peripheral pulmonary delivery.
first_indexed 2024-03-05T23:17:53Z
format Article
id oai:generic.eprints.org:31882
institution International Islamic University Malaysia
language English
last_indexed 2024-03-05T23:17:53Z
publishDate 2013
publisher Informa Healthcare
record_format dspace
spelling oai:generic.eprints.org:318822014-12-08T09:40:50Z http://irep.iium.edu.my/31882/ Microencapsulation of alpha-mangostin into PLGA microspheres and optimization using response surface methodology intended for pulmonary delivery Elsaid Ali, Aimen Abdo Bakhtiar, M. Taher Mohamed, Farahidah RS Pharmacy and materia medica Documented to exhibit cytotoxicity and poor oral bioavailability, alpha-mangostin was encapsulated into PLGA microspheres with optimization of formulation using response surface methodology. Mixed levels of four factors Face central composite design was employed to evaluate critical formulation variables. With 30 runs, optimized formula was 1% w/v polyvinyl alcohol, 1:10 ratio of oil to aqueous and sonicated at 2 and 5 min time for primary and secondary emulsion, respectively. Optimized responses for encapsulation efficiency, particle size and polydispersity index were found to be 39.12 ± 0.01%, 2.06 ± 0.017 µm and 0.95 ± 0.009, respectively, which matched values predicted by mathematical models. About 44.4% of the encapsulated alpha-mangostin was released over 4 weeks. Thermal analysis of the microspheres showed physical conversion of alpha-mangostin from crystallinity to amorphous with encapsulated one had lower in vitro cytotoxicity than free alpha-mangostin. Aerodynamic diameter (784.3 ± 7.5 nm) of this alpha-mangostin microsphere suggests suitability for peripheral pulmonary delivery. Informa Healthcare 2013-04-30 Article PeerReviewed application/pdf en http://irep.iium.edu.my/31882/1/Microencapsulation_of_alpha_mangostin_J_Micro.pdf Elsaid Ali, Aimen Abdo and Bakhtiar, M. Taher and Mohamed, Farahidah (2013) Microencapsulation of alpha-mangostin into PLGA microspheres and optimization using response surface methodology intended for pulmonary delivery. Journal of Microencapsulation. pp. 1-13. ISSN 1464-5246 (O), 0265-2048 (P) http://informahealthcare.com/doi/abs/10.3109/02652048.2013.788081 10.3109/02652048.2013.788081
spellingShingle RS Pharmacy and materia medica
Elsaid Ali, Aimen Abdo
Bakhtiar, M. Taher
Mohamed, Farahidah
Microencapsulation of alpha-mangostin into PLGA microspheres and optimization using response surface methodology intended for pulmonary delivery
title Microencapsulation of alpha-mangostin into PLGA microspheres and optimization using response surface methodology intended for pulmonary delivery
title_full Microencapsulation of alpha-mangostin into PLGA microspheres and optimization using response surface methodology intended for pulmonary delivery
title_fullStr Microencapsulation of alpha-mangostin into PLGA microspheres and optimization using response surface methodology intended for pulmonary delivery
title_full_unstemmed Microencapsulation of alpha-mangostin into PLGA microspheres and optimization using response surface methodology intended for pulmonary delivery
title_short Microencapsulation of alpha-mangostin into PLGA microspheres and optimization using response surface methodology intended for pulmonary delivery
title_sort microencapsulation of alpha mangostin into plga microspheres and optimization using response surface methodology intended for pulmonary delivery
topic RS Pharmacy and materia medica
url http://irep.iium.edu.my/31882/1/Microencapsulation_of_alpha_mangostin_J_Micro.pdf
work_keys_str_mv AT elsaidaliaimenabdo microencapsulationofalphamangostinintoplgamicrospheresandoptimizationusingresponsesurfacemethodologyintendedforpulmonarydelivery
AT bakhtiarmtaher microencapsulationofalphamangostinintoplgamicrospheresandoptimizationusingresponsesurfacemethodologyintendedforpulmonarydelivery
AT mohamedfarahidah microencapsulationofalphamangostinintoplgamicrospheresandoptimizationusingresponsesurfacemethodologyintendedforpulmonarydelivery